|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
17 October 2012 |
|
Main ID: |
NCT00526552 |
|
Date of registration:
|
05/09/2007 |
|
Primary sponsor: |
|
|
Public title:
|
Crestor RAPID (The Efficacy of RosuvAstatin for Korean Dyslipidemia PatIents With Diabetes)
RAPID |
|
Scientific title:
|
RAPID (Evaluating the Efficacy of RosuvAstatin for Korean Dyslipidemia PatIents With Diabetes in Real World Practice) |
|
Date of first enrolment:
|
June 2007 |
|
Target sample size:
|
5000 |
|
Recruitment status: |
Completed |
|
URL:
|
http://clinicaltrials.gov/show/NCT00526552 |
|
Study type:
|
Observational |
|
Study design:
|
Observational Model: Case-Only, Time Perspective: Prospective
|
|
|
Countries of recruitment
|
|
Korea, Republic of
| | | | | | | |
|
Contacts
|
|
Name:
|
Hyunah Caroline Choi |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
AstraZeneca Korea |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Hyperlipidemia patients who are prescribed with rosuvastatin 10mg, based on clinical
grounds and fulfil the following criteria
1. Over 18 years of age
2. Diagnosed with DM based on fasting or post-load glucose data and/or clinical
assessment by the clinician
Exclusion Criteria:
1. Patients already taking other hyperlipidemic agents
2. Patients who do not fulfil the indication criteria for statin therapy
3. Patients who do not have baseline and/or follow-up lipid data to verify the efficacy
data
Age minimum:
18 Years
Age maximum:
N/A
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Diabetes
|
|
Dyslipidemia
|
|
Secondary ID(s)
|
|
NIS-CKR-CRE-2007/3
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|